A Pilot Study Of Using Pre- And Early (1 Week) [18f]-misonidazole Positron Emission And Computed Tomography (18F-FMISO PET/CT) Scans As An Early Treatment Response Predictor In A Series Of Head and Neck Cancer (HNC) Patients Undergoing Chemoradiation

被引：0
|
作者：
Lee, N. [1 ]
Bartlett, R. [1 ]
Lian, M. [1 ]
Fury, M. [1 ]
Sherman, E. [1 ]
Wong, R. [1 ]
Zanzonico, P. B. [1 ]
Schoeder, H. [1 ]
Humm, J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S497 / S497
页数：1
相关论文
共 50 条
  • [41] Baseline and early digital [18F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study
    Vuijk, Floris A.
    Shahbazi, Shirin Feshtali
    Noortman, Wyanne A.
    van Velden, Floris H. P.
    Dibbets-Schneider, Petra
    Marinelli, Andreas W. K. S.
    Neijenhuis, Peter A.
    Schmitz, Roderick
    Ghariq, Eidrees
    Velema, Laura A.
    Peters, Femke P.
    Smit, Frits
    Peeters, Koen C. M. J.
    Temmink, Sofieke J. D.
    Crobach, Stijn A. L. P.
    Putter, Hein
    Vahrmeijer, Alexander L.
    Hilling, Denise E.
    de Geus-Oei, Lioe-Fee
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (07) : 613 - 621
  • [42] Response to the Letter to the Editor Regarding the Manuscript Entitled “Positron Emission Tomography with [18F]-3′-Deoxy-3′Fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study”
    Farrokh Dehdashti
    Perry W. Grigsby
    Barry A. Siegel
    Molecular Imaging and Biology, 2013, 15 : 786 - 787
  • [43] Response to the Letter to the Editor Regarding the Manuscript Entitled "Positron Emission Tomography with [18F]-3'-Deoxy-3'Fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study"
    Dehdashti, Farrokh
    Grigsby, Perry W.
    Siegel, Barry A.
    MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (06) : 786 - 787
  • [44] Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2-deoxy-2-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC)
    Fledelius, Joan
    Khalil, Azza Ahmed
    Hjorthaug, Karin
    Frokiaer, Jorgen
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2016, 60 (02) : 231 - 238
  • [45] Evaluation of circulating tumor cells (CTCs) enumeration and 18F-Choline positron emission tomography/computed tomography (FCH PET/CT) as early efficacy response biomarkers in metastatic castration-resistant prostate cancer (CRPC) patients (pts) treated with abiraterone acetate
    Le Moulec, Sylvestre
    Massard, Christophe
    Gontier, Eric
    Farace, Francoise
    Chargari, Cyrus
    Vielh, Philippe
    Aupee, Olivier
    Vedrine, Lionel
    Foehrenbach, Herve
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [46] Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer
    Hanamoto, Atsushi
    Takenaka, Yukinori
    Shimosegawa, Eku
    Ymamamoto, Yoshifumi
    Yoshii, Tadashi
    Nakahara, Susumu
    Hatazawa, Jun
    Inohara, Hidenori
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (10) : 880 - 885
  • [47] Limitation of 2-deoxy-2-[F-18]fluoro-d-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer
    Atsushi Hanamoto
    Yukinori Takenaka
    Eku Shimosegawa
    Yoshifumi Ymamamoto
    Tadashi Yoshii
    Susumu Nakahara
    Jun Hatazawa
    Hidenori Inohara
    Annals of Nuclear Medicine, 2013, 27 : 880 - 885
  • [48] To Study the Correlation Between Early Treatment Response of Non-Small Cell Lung Cancer Patients with Radiotherapy and the Quantitative Metabolic Parameters From Pre-Treatment 18F-FDG PET/CT
    Ma, C.
    Deng, H.
    Yin, Y.
    MEDICAL PHYSICS, 2017, 44 (06)
  • [49] Prognostic Value of 2-[18F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria
    Min, M.
    Linyx, P.
    Lee, M.
    Shon, I. Ho
    Lin, M.
    Forstner, D.
    Tieu, M. T.
    Chicco, A.
    Bray, V.
    Fowler, A.
    CLINICAL ONCOLOGY, 2016, 28 (06) : 393 - 401
  • [50] [18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase Inhibitors
    Seifert, Robert
    Kuper, Alina
    Tewes, Mitra
    Heuschmid, Martin
    Welt, Anja
    Fendler, Wolfgang P.
    Herrmann, Ken
    Decker, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (7-8) : 400 - 407
12345